Emmessar Biotech & Nutrition has informed that the Board of Directors at their meeting held today April 24, 2025 has transacted the following items of business: Financial Results: The Board of Directors approved the Audited Standalone Financial Results for the year ended 31.03.2025 along with the Statement of Assets and Liabilities for the year ended 31.03.2025 in the specified format along with the Auditors Report thereon. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting(s) held on April 24, 2025. The company has enclosed are the Audited statements and declaration on Audit report with unmodified opinion. The Meeting commenced at 12:10 pm and concluded at 14.25 pm.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1696.65 |
| Dr. Reddys Lab | 1218.30 |
| Cipla | 1226.65 |
| Zydus Lifesciences | 936.00 |
| Lupin | 2339.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: